Increase of endocan, a new marker for inflammation and endothelial dysfunction, in acute kidney injury.


GÜNAY M., MERTOĞLU C.

Northern Clinics of Istanbul, cilt.6, ss.124-128, 2019 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 6
  • Basım Tarihi: 2019
  • Doi Numarası: 10.14744/nci.2018.70446
  • Dergi Adı: Northern Clinics of Istanbul
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.124-128
  • Anahtar Kelimeler: Acute kidney injury, endocan or endothelial cell-specific molecule 1 (ESM 1), vitamin D, VITAMIN-D, MINERAL METABOLISM, BIOMARKERS, DISEASE, HYPERTENSION, INDICATOR, STAGE
  • İnönü Üniversitesi Adresli: Hayır

Özet

OBJECTIVE: In this study, the clinical relevance of the levels of serum endocan and 25-hydroxyvitamin D [25(OH)D] was investigated in patients with acute kidney injury (AKI). Endocan or the endothelial cell-specific molecule 1 is a soluble proteoglycan secreted by vascular endothelial cells. It plays a significant role in immunity, inflammation, and endothelial function.